{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T20:15:08Z","timestamp":1747167308628,"version":"3.40.5"},"reference-count":39,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"am","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.mayocp.2023.05.030","type":"journal-article","created":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T11:04:15Z","timestamp":1704366255000},"page":"754-765","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Outcomes Associated With Left Atrial Appendage Occlusion Via Implanted Device in Atrial Fibrillation"],"prefix":"10.1016","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2639-9593","authenticated-orcid":false,"given":"Baptiste","family":"Maille","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Defaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sid Ahmed","family":"Bentounes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julien","family":"Herbert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Michel","family":"Clerc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bertrand","family":"Pierre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Torras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean Claude","family":"Deharo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9267-1658","authenticated-orcid":false,"given":"Laurent","family":"Fauchier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.mayocp.2023.05.030_bib1","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1136\/hrt.82.5.547","article-title":"Left atrial appendage: structure, function, and role in thromboembolism","volume":"82","author":"Al-Saady","year":"1999","journal-title":"Heart"},{"issue":"9","key":"10.1016\/j.mayocp.2023.05.030_bib2","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.116.004984","article-title":"Left atrial and left atrial appendage 4D blood flow dynamics in atrial fibrillation","volume":"9","author":"Markl","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"issue":"2","key":"10.1016\/j.mayocp.2023.05.030_bib3","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1161\/CIRCIMAGING.113.001317","article-title":"Complex left atrial appendage morphology and left atrial appendage thrombus formation in patients with atrial fibrillation","volume":"7","author":"Yamamoto","year":"2014","journal-title":"Circ Cardiovasc Imaging"},{"issue":"1","key":"10.1016\/j.mayocp.2023.05.030_bib4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/cvr\/cvy272","article-title":"The prothrombotic state in atrial fibrillation: pathophysiological and management implications","volume":"115","author":"Khan","year":"2019","journal-title":"Cardiovasc Res"},{"issue":"1","key":"10.1016\/j.mayocp.2023.05.030_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2014.04.029","article-title":"Prospective randomized evaluation of the watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy","volume":"64","author":"Holmes","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"22","key":"10.1016\/j.mayocp.2023.05.030_bib6","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1056\/NEJMoa2101897","article-title":"Left atrial appendage occlusion during cardiac surgery to prevent stroke","volume":"384","author":"Whitlock","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"19","key":"10.1016\/j.mayocp.2023.05.030_bib7","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1001\/jama.2014.15192","article-title":"Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial","volume":"312","author":"Reddy","year":"2014","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.mayocp.2023.05.030_bib8","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jcin.2020.09.051","article-title":"Clinical outcomes associated with left atrial appendage occlusion versus direct oral anticoagulation in atrial fibrillation","volume":"14","author":"Nielsen-Kudsk","year":"2021","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"issue":"25","key":"10.1016\/j.mayocp.2023.05.030_bib9","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1016\/j.jacc.2020.04.067","article-title":"Left atrial appendage closure versus direct oral anticoagulants in high-risk patients with atrial fibrillation","volume":"75","author":"Osmancik","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.mayocp.2023.05.030_bib10","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"issue":"24","key":"10.1016\/j.mayocp.2023.05.030_bib11","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1016\/j.jacc.2015.04.025","article-title":"Left atrial appendage closure as an alternative to warfarin for stroke prevention in atrial fibrillation","volume":"65","author":"Holmes","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.mayocp.2023.05.030_bib12","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1477-9560-12-5","article-title":"Warfarin and atrial fibrillation: from ideal to real the warfarin affaire","volume":"12","author":"Molteni","year":"2014","journal-title":"Thromb J"},{"key":"10.1016\/j.mayocp.2023.05.030_bib13","doi-asserted-by":"crossref","unstructured":"K\u00fcmler T, Strange JE, Andersen NH. Percutaneous left atrial appendage occlusion discrepancy between randomised trials and clinical practice. Open Heart. 20221;9(2):e002079.","DOI":"10.1136\/openhrt-2022-002079"},{"issue":"19","key":"10.1016\/j.mayocp.2023.05.030_bib14","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1161\/CIRCULATIONAHA.121.057063","article-title":"Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): a randomized, controlled trial","volume":"144","author":"Lakkireddy","year":"2021","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.mayocp.2023.05.030_bib15","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1161\/CIRCULATIONAHA.119.043971","article-title":"Impact of Sapien 3 Balloon-Expandable versus Evolut R Self-Expandable Transcatheter Aortic Valve implantation in patients with aortic stenosis: data from a nationwide analysis","volume":"141","author":"Deharo","year":"2020","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.mayocp.2023.05.030_bib16","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jclinepi.2010.11.015","article-title":"Hospital discharge data can be used for monitoring procedures and intensive care related to severe maternal morbidity","volume":"64","author":"Chantry","year":"2011","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"9","key":"10.1016\/j.mayocp.2023.05.030_bib17","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1161\/STROKEAHA.119.025824","article-title":"Effectiveness and safety of rivaroxaban 15 or 20 mg versus vitamin K antagonists in nonvalvular atrial fibrillation: a population-based new users high-dimensional propensity score matched cohorts study","volume":"50","author":"Blin","year":"2019","journal-title":"Stroke"},{"issue":"12","key":"10.1016\/j.mayocp.2023.05.030_bib18","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1093\/eurheartj\/ehr488","article-title":"Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182,678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study","volume":"33","author":"Friberg","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.mayocp.2023.05.030_bib19","doi-asserted-by":"crossref","unstructured":"Fauchier L, Cinaud A, Brigadeau F, et\u00a0al. Device-related thrombosis after percutaneous left atrial appendage occlusion for atrial fibrillation. J Am Coll Cardiol. 201810;71(14):1528-1536.","DOI":"10.1016\/j.jacc.2018.01.076"},{"key":"10.1016\/j.mayocp.2023.05.030_bib20","doi-asserted-by":"crossref","unstructured":"Gabet A, Chatignoux E, Billionnet C, et\u00a0al. Annual rate of newly treated atrial fibrillation by age and gender in France, 2010-2016. Eur J Epidemiol. 20201;35(12):1139-1147.","DOI":"10.1007\/s10654-019-00594-3"},{"issue":"4","key":"10.1016\/j.mayocp.2023.05.030_bib21","first-page":"788","article-title":"Left atrial appendage closure for stroke prevention in atrial fibrillation: final report from the French left atrial appendage closure registry","volume":"98","author":"Teiger","year":"2021","journal-title":"Catheter Cardiovasc Interv"},{"issue":"10","key":"10.1016\/j.mayocp.2023.05.030_bib22","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"31","key":"10.1016\/j.mayocp.2023.05.030_bib23","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1093\/eurheartj\/ehv730","article-title":"Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry","volume":"37","author":"Boersma","year":"2016","journal-title":"Eur Heart J"},{"issue":"10","key":"10.1016\/j.mayocp.2023.05.030_bib24","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.4244\/EIJY15M01_06","article-title":"Left atrial appendage occlusion for stroke prevention in atrial fibrillation: multicentre experience with the AMPLATZER cardiac plug","volume":"11","author":"Tzikas","year":"2016","journal-title":"EuroIntervention"},{"issue":"23","key":"10.1016\/j.mayocp.2023.05.030_bib25","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1016\/j.jacc.2020.08.089","article-title":"Left atrial appendage closure versus oral anticoagulants in atrial fibrillation","volume":"76","author":"Turagam","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.mayocp.2023.05.030_bib27","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1253\/circj.CJ-12-1036","article-title":"Stroke and thromboembolism in atrial fibrillation","volume":"76","author":"Pisters","year":"2012","journal-title":"Circ J"},{"issue":"10035","key":"10.1016\/j.mayocp.2023.05.030_bib28","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1016\/S0140-6736(16)00741-8","article-title":"The novel biomarker-based ABC (age, biomarkers, clinical history)\u2013bleeding risk score for patients with atrial fibrillation: a derivation and validation study","volume":"387","author":"Hijazi","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.mayocp.2023.05.030_bib29","doi-asserted-by":"crossref","unstructured":"Wang TJ, Larson MG, Levy D, et\u00a0al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality. Circulation. 200317;107(23):2920-2925.","DOI":"10.1161\/01.CIR.0000072767.89944.6E"},{"issue":"7","key":"10.1016\/j.mayocp.2023.05.030_bib30","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1160\/TH16-12-0961","article-title":"Cessation of oral anticoagulation is an important risk factor for stroke and mortality in atrial fibrillation patients","volume":"117","author":"Rivera-Caravaca","year":"2017","journal-title":"Thromb Haemost"},{"issue":"5","key":"10.1016\/j.mayocp.2023.05.030_bib31","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/europace\/euz302","article-title":"Impact of cardiology follow-up care on treatment and outcomes of patients with new atrial fibrillation discharged from the emergency department","volume":"22","author":"Hawkins","year":"2020","journal-title":"Europace"},{"key":"10.1016\/j.mayocp.2023.05.030_bib32","doi-asserted-by":"crossref","unstructured":"Ezekowitz JA, Walraven C van, McAlister FA, Armstrong PW, Kaul P. Impact of specialist follow-up in outpatients with congestive heart failure. CMAJ. 200518;172(2):189-194.","DOI":"10.1503\/cmaj.1032017"},{"issue":"9","key":"10.1016\/j.mayocp.2023.05.030_bib33","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1161\/STROKEAHA.114.006070","article-title":"High prevalence of atrial fibrillation among patients with ischemic stroke","volume":"45","author":"Friberg","year":"2014","journal-title":"Stroke"},{"issue":"12","key":"10.1016\/j.mayocp.2023.05.030_bib34","first-page":"1629","article-title":"Incidence and clinical impact of device-related thrombus following percutaneous left atrial appendage occlusion","volume":"4","author":"Alkhouli","year":"2018","journal-title":"J\u00a0Am Coll Cardiol EP"},{"issue":"6","key":"10.1016\/j.mayocp.2023.05.030_bib35","first-page":"766","article-title":"Clinical impact of residual leaks following left atrial appendage occlusion: insights from the NCDR LAAO registry","volume":"8","author":"Alkhouli","year":"2022","journal-title":"J\u00a0Am Coll Cardiol EP"},{"issue":"16","key":"10.1016\/j.mayocp.2023.05.030_bib36","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1001\/jama.2009.1488","article-title":"Cardiovascular and noncardiovascular mortality among patients starting dialysis","volume":"302","author":"Jager","year":"2009","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.mayocp.2023.05.030_bib37","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1378\/chest.15-1719","article-title":"Stroke, major bleeding, and mortality outcomes in warfarin users with atrial fibrillation and chronic kidney disease","volume":"149","author":"Dahal","year":"2016","journal-title":"Chest"},{"issue":"16","key":"10.1016\/j.mayocp.2023.05.030_bib38","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/j.jcin.2021.06.008","article-title":"The association of chronic kidney disease with outcomes following percutaneous left atrial appendage closure","volume":"14","author":"Ahuja","year":"2021","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.mayocp.2023.05.030_bib39","first-page":"475","article-title":"Estimating the prevalence of atrial fibrillation in a general population using validated electronic health data","volume":"5","author":"Norberg","year":"2013","journal-title":"Clin Epidemiol"},{"issue":"4","key":"10.1016\/j.mayocp.2023.05.030_bib40","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/europace\/eux123","article-title":"Five year trends (2008-2012) in cardiac implantable electrical device utilization in five European nations: a case study in cross-country comparisons using administrative databases","volume":"20","author":"Banks","year":"2018","journal-title":"Europace"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002561962300304X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002561962300304X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T19:16:11Z","timestamp":1714590971000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002561962300304X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S002561962300304X"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2023.05.030","relation":{},"ISSN":["0025-6196"],"issn-type":[{"type":"print","value":"0025-6196"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes Associated With Left Atrial Appendage Occlusion Via Implanted Device in Atrial Fibrillation","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2023.05.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}